Acetazolamide for Treatment Resistant Schizophrenia
This study is recruiting. It focuses on schizophrenia and currently lists participation information in India and the United States.
Multiple locations, including Pittsburgh
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is recruiting. It focuses on schizophrenia and currently lists participation information in India and the United States.
Multiple locations, including PittsburghThis study is recruiting. It focuses on schizophrenia and currently lists participation information in the Netherlands.
In NetherlandsThis study is recruiting. It focuses on schizophrenia and currently lists participation information in Brazil, Bulgaria, Chile, Czech Republic, France, Italy, Mexico, Serbia, South Korea, Spain, Taiwan, and the United States.
Multiple locations, including ChandlerThis study is recruiting in Spain. It focuses on Schizophrenia.
In SpainThis study is recruiting. It focuses on schizophrenia and currently lists participation information in the United Kingdom.
In United KingdomThis study is recruiting. It focuses on schizophrenia and currently lists participation information in the United Kingdom.
In United KingdomThis study is recruiting in the United States. It focuses on Schizophrenia.
In BirminghamThis study is recruiting. It focuses on schizophrenia and currently lists participation information in the United Kingdom.
In United KingdomThis study is recruiting. It focuses on schizophrenia and currently lists participation information in Denmark.
In Glostrup MunicipalityThis study is recruiting. It focuses on schizophrenia and currently lists participation information in the United Kingdom and Thailand.
In United KingdomThis study is recruiting in the United Kingdom and in Thailand. It focuses on schizophrenia.
In United KingdomThis study is recruiting. It focuses on schizophrenia and currently lists participation information in the United Kingdom and Switzerland.
In United Kingdom